Open Access Green as soon as Postprint is submitted to ZB.
Sex differences in IPF: Data from the German INSIGHTS Registry.
Respiration, DOI: 10.1159/000550309 (2026)
Background: Idiopathic pulmonary fibrosis (IPF) preferentially occurs in male patients and controversial results in gender-specific differences including overall mortality have been reported. Methods: The INSIGHTS-IPF registry was a non-interventional, prospective cohort study including IPF patients from 20 interstitial lung disease expert centers in Germany. Sex-related disparities were analyzed regarding comorbidities, clinical course, and survival. Results: Of the 1,043 IPF patients included, 842 (80.7%) were male and 201 (19.3%) were female. Male patients were more likely to have a history of smoking (p < 0.001) and environmental exposure, especially metal dust, wood dust, and solvents (p = 0.032). While males at baseline had a higher prevalence of coronary artery disease, atrial fibrillation, emphysema, and obstructive sleep apnea syndrome, in females, gastro-esophageal reflux disease and depression or depressive disorders were more frequent. Female IPF patients had more frequently a history of immunosuppressive therapy (p = 0.003). Regardless of gender, the INSIGHTS-IPF cohort as a whole showed a progressive worsening of lung function parameters over time. All-cause mortality did not differ between females and males (HR: 0.81; 95% CI: 0.63-1.04; p = 0.093) and female gender was not a significant predictor for mortality in IPF (HR 0.74; 95% CI: 0.54-1.03; p = 0.071). Interestingly, the GAP score underestimated the observed 2-year and 3-year mortality in females in GAP stage II. Conclusion: In the German INSIGHTS-IPF registry, no differences in lung function decline and survival could be observed between female and male patients with IPF, indicating differences between IPF cohorts from the USA and Europe.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Idiopathic pulmonary fibrosis; Gender; Interstitial lung disease; Comorbidities; Gender-age-physiology index; Idiopathic Pulmonary-fibrosis; Clinical-practice; Management; Diagnosis; Disease; Adults; Index
ISSN (print) / ISBN
0025-7931
e-ISSN
1423-0356
Journal
Respiration
Publisher
Karger
Publishing Place
Allschwilerstrasse 10, Ch-4009 Basel, Switzerland
Reviewing status
Peer reviewed
Institute(s)
Institute of Lung Health and Immunity (LHI)
Grants
GWT-TUD GmbH
Boehringer-Ingelheim GmbH
Boehringer-Ingelheim GmbH